- Head and neck cancer
- Lung cancer
- Thyroid cancer
Lova L. Sun, MD, MSCE
Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
Penn Medicine Provider
About me
- Assistant Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
My education and training
- University of Pennsylvania School of MedicineMedical School
- Massachusetts General HospitalResidency
- University of Pennsylvania Health SystemFellowship
Spoken languages
English
English
Reviews
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Sun is a Penn Medicine physician.
Qualifications and experience
- Medical Oncology, 2021
- ASCO (American Society of Clinical Oncology), National
- Center for Clinical Epidemiology and Biostatistics, Local
- ECOG-ACRIN, National
- ITOG (International Thyroid Oncology Group) member, International
- NCI Head and Neck Steering Committee, National
- Head and neck cancer care
- Lung cancer care
- Thyroid and parathyroid cancer care
Treatments and conditions
Research
Publications
Lova Sun, Willdragon Wang, Keelia Clemens, Kyle Chang, Leslie Bucheit, Melina E. Marmarelis, Aditi Singh, Corey J. Langer, Roger B. Cohen & Charu Aggarwal Long-term ctDNA reassessment in NSCLC immunotherapy responders , Communications Medicine: 2026
Millet YA, Spira AI, Baik CS, Hong MH, Shum E, Patel JD, Nguyen D, Janne PA, Piotrowska Z, Leighl NB, Matsumoto S, Sun L, Yang TY, Yoshida T, Nilsson MB, Heymach JV, Murray BW, Keats J, Lee S, Hsieh J, Zalutskaya A, Le X. BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR Mutations , Mol Cancer Ther: 2026
Lova Sun, Willdragon Wang, Kyle Chang, Leslie A. Bucheit, Keelia Clemens, Aditi P. Singh, Melina E. Marmarelis, Roger B. Cohen, Corey J. Langer, Charu Aggarwal Long-term ctDNA reassessment (LTctDNA) in NSCLC immunotherapy responders. , J Clin Oncol: 2026
Xavier Orcutt, Vivek Nimgaonkar, Lova Sun, Charu Aggarwal, Aaron B. Cohen, Ronac Mamtani, Qi Long, Ravi B. Parikh Machine learning risk stratification in a US-based database to identify subgroups of patients with PD-L1-high NSCLC who benefit from adding chemotherapy to pembrolizumab. , J Clin Oncol: 2026
Adam Barsouk, Jonathan H. Sussman, Maxim Yaskolko, Lova Sun, Aditi P. Singh, Charu Aggarwal, Roger B. Cohen, Melina E. Marmarelis, Corey J. Langer Performance status and tarlatamab outcomes in a large, multi-institution real-world database of 2L+ ES-SCLC. , J Clin Oncol: 2026
Rachel Jaber Chehayeb, Willdragon Wang, Lova Sun, Aditi P. Singh, Roger B. Cohen, Corey J. Langer, Charu Aggarwal, Melina E. Marmarelis Incidentally discovered lung cancer in explanted lungs at the time of lung transplantation: Management and outcomes. , J Clin Oncol: 2026
Xavier Orcutt, Vivek Nimgaonkar, Lova Sun, Charu Aggarwal, Aaron B. Cohen, Ronac Mamtani, Qi Long, Ravi B. Parikh Machine learning risk stratification in a US-based database to identify subgroups of patients with head and neck cancer who benefit from adding chemotherapy to pembrolizumab. , J Clin Oncol: 2026
Adam Barsouk, Maxim Yaskolko, Jonathan H. Sussman, Lova Sun, Roger B. Cohen, Charu Aggarwal, Corey J. Langer, Melina E. Marmarelis Sotorasib vs adagrasib in the 2L+ setting: Outcomes in a large, multi-institutional, real-world database of KRAS-G12C mutated mNSCLC , J Clin Oncol: 2026
Phurin Areesawangkit, Adam Barsouk, Maxim Yaskolko, Lucy Wang, Cole Friedes, Roger B. Cohen, Lova Sun, Charu Aggarwal, Melina E. Marmarelis, Aditi P. Singh, Kyle W. Robinson, Christopher D'Avella, Christine A. Ciunci, Steven J. Feigenberg, Jeffrey D. Bradley, Nikhil Yegya-Raman, Michelle Iocolano, Christiana Davis, Corey J. Langer Long-term survival outcomes of consolidative local ablative therapy after response to first-line systemic treatment in oligometastatic NSCLC. , J Clin Oncol: 2026
Teja Voruganti, Yi Lian, Benjamin A. Bleiberg, Lauren Reed-Guy, Roger B. Cohen, David J. Cantor, Kyle W. Robinson, Christopher D'Avella, Christine A. Ciunci, Melina E. Marmarelis, Aditi P. Singh, Corey J. Langer, Lova Sun, Charu Aggarwal SPARK-Lung: A study of patterns and outcomes in young-onset lung cancer , J Clin Oncol: 2026